14-23389063-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002471.4(MYH6):​c.3979-8C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 7 hom., cov: 0)
Exomes 𝑓: 0.0014 ( 3 hom. )

Consequence

MYH6
NM_002471.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0001091
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.275

Publications

1 publications found
Variant links:
Genes affected
MYH6 (HGNC:7576): (myosin heavy chain 6) Cardiac muscle myosin is a hexamer consisting of two heavy chain subunits, two light chain subunits, and two regulatory subunits. This gene encodes the alpha heavy chain subunit of cardiac myosin. The gene is located approximately 4kb downstream of the gene encoding the beta heavy chain subunit of cardiac myosin. Mutations in this gene cause familial hypertrophic cardiomyopathy and atrial septal defect 3. [provided by RefSeq, Feb 2017]
MYH6 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 14
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • Keppen-Lubinsky syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial septal defect 3
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 14-23389063-G-C is Benign according to our data. Variant chr14-23389063-G-C is described in ClinVar as Benign. ClinVar VariationId is 414321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0959 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH6NM_002471.4 linkc.3979-8C>G splice_region_variant, intron_variant Intron 28 of 38 ENST00000405093.9 NP_002462.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH6ENST00000405093.9 linkc.3979-8C>G splice_region_variant, intron_variant Intron 28 of 38 5 NM_002471.4 ENSP00000386041.3 P13533

Frequencies

GnomAD3 genomes
AF:
0.00925
AC:
601
AN:
64970
Hom.:
7
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00258
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000493
Gnomad SAS
AF:
0.000401
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000852
Gnomad OTH
AF:
0.00814
GnomAD2 exomes
AF:
0.00155
AC:
236
AN:
152678
AF XY:
0.00125
show subpopulations
Gnomad AFR exome
AF:
0.0146
Gnomad AMR exome
AF:
0.00114
Gnomad ASJ exome
AF:
0.000175
Gnomad EAS exome
AF:
0.000756
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00178
GnomAD4 exome
AF:
0.00135
AC:
583
AN:
431214
Hom.:
3
Cov.:
0
AF XY:
0.00118
AC XY:
249
AN XY:
210794
show subpopulations
African (AFR)
AF:
0.0450
AC:
432
AN:
9590
American (AMR)
AF:
0.00278
AC:
36
AN:
12930
Ashkenazi Jewish (ASJ)
AF:
0.000526
AC:
3
AN:
5700
East Asian (EAS)
AF:
0.00214
AC:
27
AN:
12640
South Asian (SAS)
AF:
0.000164
AC:
4
AN:
24332
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12426
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1852
European-Non Finnish (NFE)
AF:
0.000113
AC:
38
AN:
335064
Other (OTH)
AF:
0.00258
AC:
43
AN:
16680
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00924
AC:
600
AN:
64956
Hom.:
7
Cov.:
0
AF XY:
0.00866
AC XY:
278
AN XY:
32114
show subpopulations
African (AFR)
AF:
0.103
AC:
565
AN:
5492
American (AMR)
AF:
0.00257
AC:
22
AN:
8544
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1556
East Asian (EAS)
AF:
0.000495
AC:
2
AN:
4040
South Asian (SAS)
AF:
0.000402
AC:
1
AN:
2486
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6250
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
124
European-Non Finnish (NFE)
AF:
0.0000852
AC:
3
AN:
35204
Other (OTH)
AF:
0.00808
AC:
7
AN:
866
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
29
59
88
118
147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertrophic cardiomyopathy 14 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
3.2
DANN
Benign
0.88
PhyloP100
0.28
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00011
dbscSNV1_RF
Benign
0.028
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs555976716; hg19: chr14-23858272; API